News Shares

After Hours, IEA And Others Spike

Sponsored

Infrastructure and Energy Alternatives Inc. 19.4 percent higher; established a venture that is joint F.H. Paschen for the West Lake Corridor rail expansion awarded by the Northern Indiana Commuter Transportation District (NICTD) and respected at over $550 million. The contract had been secured by Ragnar Benson, a subsidiary of IEA that provides heavy- and construction that is light-rail and F.H. Paschen, a general contractor and construction supervisor with more than 110 several years of expertise in the construction industry.

SolarEdge Technologies (NASDAQ: SEDG) 19% DECREASE; reported Q3 EPS of $1.21, $0.39 much better than the analyst estimate of $0.82. Income for the quarter arrived in at $338.1 million versus the opinion estimate of $342.33 million. SolarEdge Technologies sees Q4 2020 income of $345-365 million, versus the consensus of $389.6 million.

Arista Networks (NYSE: ANET) 10.3percent HIGHER; reported Q3 EPS of $2.42, $0.21 much better than the analyst estimate of $2.21. Income for the quarter arrived in at $605.4 million versus the consensus estimate of $581.33 million. Arista Networks sees Q4 2020 income of $615-635 million, versus the opinion of $609.25 million.

Inspire Medical techniques (NYSE: INSP) 10% HIGHER; reported Q3 EPS of ($0.39), $0.33 a lot better than the analyst estimate of ($0.72). Revenue for the quarter arrived in at $35.8 million versus the opinion estimate of $22.75 million. Inspire Medical Systems sees FY2020 revenue of $110-112 million, versus the opinion of $90.19 million.

Jazz Pharmaceuticals (NASDAQ: JAZZ) 8% HIGHER; reported Q3 EPS of $4.31, $0.23 much better than the analyst estimate of $4.08. Income for the quarter arrived in at $600.89 million versus the consensus estimate of $577.58 million.

Cirrus Logic, Inc. (NASDAQ: CRUS) 8% HIGHER; reported Q2 EPS of $1.26, $0.36 a lot better than the analyst estimate of $0.90. Income for the quarter arrived in at $347.3 million versus the opinion estimate of $310.56 million. Cirrus Logic, Inc. sees Q3 2021 revenue of $440-480 million, versus the opinion of $354.4 million.

Halozyme Therapeutics (NASDAQ: HALO) 7.8% HIGHER; reported Q3 EPS of $0.25, $0.06 better than the analyst estimate of $0.19. Income for the quarter came in at $65.3 million versus the consensus estimate of $60.9 million. Halozyme Therapeutics sees FY2020 EPS of $0.80-$0.85, versus the consensus of $0.69. Halozyme Therapeutics sees revenue that is FY2020 of250-260 million, versus the consensus of $235.94 million. Infrastructure and Energy Alternatives Inc. 19.4 percent higher.

Sponsored

Billy Houghton

Billy Houghton is a top acclaimed and sought-after commodities futures trading expert. The expertise and in-depth level of analysis that is offered by Billy Houghton is what has managed to put him at the stage of being the top ranked author for MetaNews among multiple different categories. Throughout his career, Billy has specifically spent over three decades on Wall Street fine-tuning his skills, which included over two decades at a trading desk. In more recent times, specifically the last decade, Billy has been researching algorithms of AI in futures trading, and believes they are the future of trading.
Follow Me:

Related Posts

Sponsored
Sponsored